Canexia’s precision cancer assays digitize biologic samples and make high-quality cancer genomic information accessible and affordable.
Our targeted assays are cost-effective, rapidly scalable, and available for tissue or blood samples. Safely optimize and validate tests within your own laboratory—library preparation, sequencing, report issuing, and sign-off take place at your location.
Tailor treatment decisions based on somatic mutations in your patient’s tumor.
A minimally invasive option for biopsy, Follow It can also be used to monitor cancer progression or investigate treatment resistance.
Rapid, cost-effective, and clinically actionable, Fusions allows you the flexibility to isolate and interrogate relevant fusions.
Each comprehensive report includes detailed results as well as therapeutic recommendations and expertly curated clinical trials. Our insights can help you make more informed treatment decisions.
Access Canexia Health’s full stack of bioinformatics, reporting, and quality assurance tools, right from the cloud.
Contact us to learn more about our assays, informatics, or support, and learn more about becoming a Canexia Health partner.
In this presentation, Dr. Gregory Tranah, of Sutter Health, discusses opportunities and challenges that bringing in-house testing to a large, complex, health system presents. Dr. Tranah will discuss critical success factors for others who are considering embarking on this path.